NVCR
Price
$16.98
Change
-$0.96 (-5.35%)
Updated
Apr 3 closing price
Capitalization
1.66B
27 days until earnings call
TWST
Price
$34.10
Change
-$3.40 (-9.07%)
Updated
Apr 4, 11:47 AM (EDT)
Capitalization
1.98B
27 days until earnings call
Ad is loading...

NVCR vs TWST

Header iconNVCR vs TWST Comparison
Open Charts NVCR vs TWSTBanner chart's image
NovoCure
Price$16.98
Change-$0.96 (-5.35%)
Volume$664.81K
Capitalization1.66B
Twist Bioscience
Price$34.10
Change-$3.40 (-9.07%)
Volume$2.64K
Capitalization1.98B
NVCR vs TWST Comparison Chart
Loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVCR vs. TWST commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCR is a StrongBuy and TWST is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (NVCR: $16.98 vs. TWST: $37.50)
Brand notoriety: NVCR and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVCR: 76% vs. TWST: 161%
Market capitalization -- NVCR: $1.66B vs. TWST: $1.98B
NVCR [@Medical Specialties] is valued at $1.66B. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCR’s FA Score shows that 1 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • NVCR’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, both NVCR and TWST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 4 TA indicator(s) are bullish while TWST’s TA Score has 4 bullish TA indicator(s).

  • NVCR’s TA Score: 4 bullish, 4 bearish.
  • TWST’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than TWST.

Price Growth

NVCR (@Medical Specialties) experienced а -10.49% price change this week, while TWST (@Medical Specialties) price change was -9.81% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.65%. For the same industry, the average monthly price growth was +1.31%, and the average quarterly price growth was +1.17%.

Reported Earning Dates

NVCR is expected to report earnings on May 01, 2025.

TWST is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (-4.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.98B) has a higher market cap than NVCR($1.66B). TWST YTD gains are higher at: -19.303 vs. NVCR (-43.020). TWST (-172.41M) and NVCR (-177.45M) have comparable annual earnings (EBITDA) . NVCR has more cash in the bank: 911M vs. TWST (311M). TWST has less debt than NVCR: TWST (91.9M) vs NVCR (596M). NVCR has higher revenues than TWST: NVCR (509M) vs TWST (262M).
NVCRTWSTNVCR / TWST
Capitalization1.66B1.98B84%
EBITDA-177.45M-172.41M103%
Gain YTD-43.020-19.303223%
P/E RatioN/AN/A-
Revenue509M262M194%
Total Cash911M311M293%
Total Debt596M91.9M649%
FUNDAMENTALS RATINGS
NVCR vs TWST: Fundamental Ratings
NVCR
TWST
OUTLOOK RATING
1..100
7466
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
5957
P/E GROWTH RATING
1..100
7100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for NVCR (100) in the Medical Specialties industry. This means that TWST’s stock grew somewhat faster than NVCR’s over the last 12 months.

TWST's Profit vs Risk Rating (94) in the Biotechnology industry is in the same range as NVCR (100) in the Medical Specialties industry. This means that TWST’s stock grew similarly to NVCR’s over the last 12 months.

TWST's SMR Rating (97) in the Biotechnology industry is in the same range as NVCR (97) in the Medical Specialties industry. This means that TWST’s stock grew similarly to NVCR’s over the last 12 months.

TWST's Price Growth Rating (57) in the Biotechnology industry is in the same range as NVCR (59) in the Medical Specialties industry. This means that TWST’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for TWST (100) in the Biotechnology industry. This means that NVCR’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCRTWST
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIRCX19.91N/A
N/A
BlackRock Sustainable Adg Lg Cp Cr C
BRSHX12.80N/A
N/A
MFS Blended Research Small Cap Eq C
TRAOX15.75N/A
N/A
T. Rowe Price Asia Opportunities
MIEJX36.17N/A
N/A
MFS International Equity A
BRBCX13.75-0.28
-2.00%
BlackRock Tactical Opportunities Inv C

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with FLGT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-5.35%
FLGT - NVCR
35%
Loosely correlated
-3.52%
KIDS - NVCR
35%
Loosely correlated
-10.22%
NEO - NVCR
34%
Loosely correlated
-7.43%
TWST - NVCR
34%
Loosely correlated
-1.86%
BLFS - NVCR
34%
Loosely correlated
-5.63%
More